Biologic Imaging Reagents Global Market Report 2024 - By Trends, Size, Share, Demand, Forecast To 2033

"The new report published by The Business Research Company, titled ""Biologic Imaging Reagents Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the biologic imaging reagents market size has grown rapidly in recent years. It will grow from $16.69 billion in 2023 to $18.41 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The biologic imaging reagents market size is expected to see strong growth in the next few years. It will grow to $25.72 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13389&type=smp

Chronic Disease Prevalence Fuels Growth of Biologic Imaging Reagents Market
The increase in the prevalence of chronic diseases is expected to propel the growth of the biologic imaging reagents market going forward. Chronic diseases refer to conditions that last one year or longer and require continuous medical attention, which may worsen over time. Chronic diseases require biologic imaging reagents to diagnose and detect diseases by visualizing organs and affected structures. For instance, in 2022, according to the American Cancer Society, a US-based voluntary organization, the number of new cancer cases and fatalities expected was estimated to be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. Furthermore, in December 2021, according to the IDF Diabetes Atlas Tenth Edition 2021 report published by the International Diabetes Federation, a Belgium-based umbrella organization of national diabetes associations, 537 million persons (20-79 years old) were estimated to have diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. The increase in the prevalence of chronic diseases is driving the growth of the biologic imaging reagents market.

Innovative Reagents Revolutionize Biologic Imaging
Major companies operating in the biologic imaging reagents market are focusing on developing innovative reagents, such as novel dye technology, offering researchers and clinicians a new tool for visualizing and improving the sensitivity and specificity of biologic imaging. Novel dye technology refers to developing new dyes for various applications, including biological imaging. For instance, in April 2022, Becton, Dickinson, and Company, a US-based medical device company, launched BD Horizon RealYellow 586 Reagents and RealBlue Reagents. This new family of reagents allows researchers to acquire higher data resolution and more insights from samples than standard fluorochrome. It is due to employing revolutionary dye technology and artificial intelligence (AI) supervision. The AI assessed existing data from excitation and emission profiles of commercially available fluorochromes and then determined the best places in laser lines to develop novel dyes.

The biologic imaging reagents market covered in this report is segmented -
1) By Product: Contrast Reagents, Optical Imaging Reagents, Radiopharmaceuticals
2) By Modality: Magnetic Resonance Imaging (MRI), Ultrasound, X-Ray And Computerized Tomography (CT), Nuclear, Optical Imaging, Other Modalites
3) By Application: In Vitro, In Vivo
4) By End User: Diagnostic Laboratories, Imaging Centres, Life Science Companies, Research And Academic Institutes, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13389&type=discount

Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc. , PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Württemberg GmbH, ABX Advanced Biochemical Compounds GmbH

Contents of the report:
1. Executive Summary
2. Biologic Imaging Reagents Market Report Structure
3. Biologic Imaging Reagents Market Trends And Strategies
4. Biologic Imaging Reagents Market - Macro Economic Scenario
5. Biologic Imaging Reagents Market Size And Growth
…..
27. Biologic Imaging Reagents Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/biologic-imaging-reagents-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.